Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine

This publication has 66 references indexed in Scilit:

• Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
  Trends in Neurosciences, 2013
• Parkinson disease: from pathology to molecular disease mechanisms
  Free Radical Biology and Medicine, 2013
• New Agents Promote Neuroprotection in Parkinson’s Disease Models
  CNS & Neurological Disorders - Drug Targets, 2012
• Depression in Parkinson disease—epidemiology, mechanisms and management
  Nature Reviews Neurology, 2011
• Gene Therapy in Parkinsonʼs Disease
  CNS Drugs, 2010
• Treatment strategies for Parkinson’s disease
  Neuroscience Bulletin, 2010
• Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
  The Lancet Neurology, 2009
• Parkinson's disease: clinical features and diagnosis
  Journal of Neurology, Neurosurgery & Psychiatry, 2008
• The parkinson's complex: Parkinsonism is just the tip of the iceberg
  Annals of Neurology, 2006
• Non-motor symptoms of Parkinson's disease: diagnosis and management
  The Lancet Neurology, 2006